文献速递姑息放疗与转移瘤放疗物理与技术

八十多岁老年骨转移患者的姑息性放疗:最高龄人群反应如何?来自三级癌症中心288例治疗患者的结果

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients.
PubMed 文献 · Radiat Oncol · 2022-09-07

研究回顾性分析了2009至2019年间一家三级癌症中心80至89岁接受骨转移放疗的288例患者共516个照射病灶,评估治疗模式、疼痛反应和总生存。放疗结束时176例(61%)疼痛减轻,首次随访时84例(29%)达到完全疼痛缓解,双膦酸盐使用与首次随访时更高的疼痛反应率显著相关(p<0.05)。中位总生存为9个月,1年、2年和3年总生存率分别为43%、28%和17%。

要点

  • 80至89岁骨转移患者姑息性放疗后61%疼痛减轻,29%首次随访完全缓解。
  • 双膦酸盐使用与首次随访时更高的疼痛反应率显著相关(p<0.05)。
  • ECOG、Mizumoto评分和SINS是多变量分析中总生存的独立预后因素。

核心结论

  • 作者认为,对八十多岁患者骨转移行姑息性放疗是可行且有效的镇痛治疗。
  • ECOG、Mizumoto评分和SINS是生存的预后变量,可能有助于该患者群体放疗分次的治疗决策。
  • 作者提出,对无并发症骨转移且预后差的患者应给予8 Gy单次放疗;需要前瞻性试验关注这些高龄骨转移癌症患者的生活质量,以揭示该脆弱人群的最佳放疗管理。

研究设计与样本

  • 回顾性分析2009至2019年间在一家三级癌症中心接受骨转移放疗的80至89岁患者,分析治疗模式、疼痛反应和总生存。
  • 共纳入288例患者、516个照射病灶;采用逻辑回归分析疼痛反应相关参数,采用Cox分析总生存的预后参数。

主要发现

  • 288例患者中249例(86%)完成了全部放疗疗程。
  • 放疗结束时176例(61%)疼痛减轻;首次随访时84例(29%)达到完全疼痛缓解。
  • 双膦酸盐使用与首次随访时更高的疼痛反应率显著相关(p<0.05)。
  • 中位总生存为9个月,1年、2年和3年总生存率分别为43%、28%和17%。
  • 多变量分析中,ECOG(p<0.001)、Mizumoto评分(p<0.01)和SINS(p<0.001)是总生存的独立预后因素。

临床怎么用

  • 作者提出,对无并发症骨转移且预后差的患者应给予8 Gy单次放疗。
  • 作者认为ECOG、Mizumoto评分和SINS可能有助于该患者群体放疗分次的治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accompanied by the demographic change, the number of octogenarian cancer patients with bone metastases will increase in the future. Palliative radiotherapy constitutes an effective analgesic treatment; however, as pain perception and bone metabolism change with increasing age, the analgesic efficacy of radiotherapy may be altered in elderly patients. We therefore investigated the treatment outcomes of palliative radiotherapy for bone metastases in octogenarians. METHODS: Patients between 80 and 89 years undergoing radiotherapy for bone metastases between 2009 and 2019 at a tertiary cancer center were analyzed for patterns-of-care, pain response and overall survival (OS). Logistic regression analyses were carried out to examine parameters associated with pain response, and Cox analyses were conducted to reveal prognostic parameters for OS. RESULTS: A total of 288 patients with 516 irradiated lesions were included in the analysis. The majority (n = 249, 86%) completed all courses of radiotherapy. Radiotherapy led to pain reduction in 176 patients (61%) at the end of treatment. Complete pain relief at the first follow-up was achieved in 84 patients (29%). Bisphosphonate administration was significantly associated with higher rates of pain response at the first follow-up (p < 0.05). Median OS amounted to 9 months, and 1-year, 2-year and 3-year OS were 43%, 28% and 17%. In the multivariate analysis, ECOG (p < 0.001), Mizumoto score (p < 0.01) and Spinal Instability Neoplastic Score (SINS) (p < 0.001) were independent prognosticators for OS. CONCLUSION: Palliative radiotherapy for bone metastases constitutes a feasible and effective analgesic treatment in octogenarian patients. ECOG, Mizumoto score and SINS are prognosic variables for survival and may aid treatment decisions regarding radiotherapy fractionation in this patient group. Single-fraction radiotherapy with 8 Gy should be applied for patients with uncomplicated bone metastases and poor prognosis. Prospective trials focusing on quality of life of these very old cancer patients with bone metastases are warranted to reveal the optimal radiotherapeutic management for this vulnerable population.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Rühle A, Nya Yompang VA, Spohn SKB, et al. Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients. Radiat Oncol. 2022. PMID: 36071522. doi:10.1186/s13014-022-02122-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。